LC-MS/MS studies of ritonavir and its forced degradation products

Journal of Pharmaceutical and Biomedical Analysis

Volumn 53, Issue 4, 2010, Pages 833-842

  Rao, R Nageswara ^a   Ramachandra, B ^a   Vali, R Mastan ^a   Raju, S Satyanarayana ^a  

^a INDIAN INSTITUTE OF CHEMICAL TECHNOLOGY   (India)

Author keywords

Antiretroviral; Forced degradation; Fragment ions; LC APCI MS MS; Ritonavir

Indexed keywords

ACETONITRILE; METHANOL; RITONAVIR; WATER;

ANALYTICAL EQUIPMENT; ARTICLE; DRUG DEGRADATION; DRUG HYDROLYSIS; DRUG OXIDATION; ELUTION; LIQUID CHROMATOGRAPHY; PHOTOLYSIS; PRIORITY JOURNAL; PROCESS OPTIMIZATION; TANDEM MASS SPECTROMETRY; TEMPERATURE STRESS; VALIDATION STUDY;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHROMATOGRAPHY, LIQUID; DRUG STABILITY; HIV PROTEASE INHIBITORS; HYDROLYSIS; RITONAVIR; TANDEM MASS SPECTROMETRY;

EID: 77955569708     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2010.06.004     Document Type: Article

References (17)

1. Dias C.L., Rossi R.C., Donato E.M., Bergold A.M., Fröehlich P.E. LC determination of ritonavir, a HIV protease inhibitor, in soft gelatin capsules. Chromatographia 2005, 62:589-593.
2. Yekkala R.S., Ashenafi D., Mariën I., Xin H., Haghedooren E., Hoogmartens J., Adams E. Evaluation of an international pharmacopoeia method for the analysis of ritonavir by liquid chromatography. J. Pharm. Biomed. Anal. 2008, 48:1050-1054.
3. Donato E.M., Dias C.L., Rossi R.C., Valente R.S., Fröehlich P.E., Bergold A.M. LC method for studies on the stability of lopinavir and ritonavir in soft gelatin capsules. Chromatographia 2006, 63:437-443.
4. Usami Y., Oki T., Nakai M., Sagisaka M., Kaneda T. A simple HPLC method for simultaneous determination of lopinavir, ritonavir and efavirenz. Chem. Pharm. Bull. 2003, 51:715-718.
5. Sulebhavikar A.V., Pawar U.D., Mangoankar K.V., Prabhu Navelkar N.D. HPTLC method for simultaneous determination of lopinavir and ritonavir in capsule dosage form. E-J. Chem. 2008, 5:706-712.
6. Gutleben W., Tuan N.D., Stoiber H., Dierich M.P., Sarcletti M., Zemann A. Capillary electrophoretic separation of protease inhibitors used in human immunodeficiency virus therapy. J. Chromatogr. A 2001, 922:313-320.
7. Wang P.G., Wei J.S., Kim G., Chang M., El-Shourbagy T. Validation and application of a high-performance liquid chromatography-tandem mass spectrometric method for simultaneous quantification of lopinavir and ritonavir in human plasma using semi-automated 96-well liquid-liquid extraction. J. Chromatogr. A 2006, 1130:302-307.
8. Rentsch K.M. Sensitive and specific determination of eight antiretroviral agents in plasma by high-performance liquid chromatography-mass spectrometry. J. Chromatogr. B 2003, 788:339-350.
9. Gangl E., Utkin I., Gerber N., Vouros P. Structural elucidation of metabolites of ritonavir and indinavir by liquid chromatography-mass spectrometry. J. Chromatogr. A 2002, 974:91-101.
10. Stability testing of new drug substances and products, QIA (R2). Proceeding of International Conference on Harmonization (ICH) 2003.
11. Gehrig A.-K., Mikus G., Haefeli W.E., Burhenne J. Electrospray tandem mass spectroscopic characterisation of 18 antiretroviral drugs and simultaneous quantification of 12 antiretrovirals in plasma. Rapid Commun. Mass Spectrom. 2007, 21:2704-2716.
12. Wysocki V.H., Resing K.A., Zhang Q., Cheng G. Mass spectrometry of peptides and proteins. Methods 2005, 35:211-222.
13. n. J. Pharm. Biomed. Anal. 2009, 49:55-63.
14. Bansal G., Singh M., Jindal K.C., Singh S. LC-UV-PDA and LC-MS studies to characterize degradation products of glimepiride. J. Pharm. Biomed. Anal. 2008, 48:788-795.
15. British Pharmacopoeia Monographs: Medicinal and Pharmaceutical substances, Ritonavir, Volume I and II, 2009.
16. The United States Pharmacopeia-National Formulary, 3 (2007) 3143-3145.
17. European Pharmacopeia, 6 (2008) 2832-2835.